S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 10,981 to 11,000 of 19,875

Issue Date	Title / Author(s) / Citation	File
2020-04	Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies Chung, Hyun Cheol; Piha-Paul, Sarina A.; Lopez-Martin, Jose; Schellens, Jan H. M.; Kao, Steven; Miller, Wilson H., Jr.; Delord, Jean-Pierre; Gao, Bo; Planchard, David; Gottfried, Maya; Zer, Alona; Jalal, Shadia I.; Penel, Nicolas; Mehnert, Janice M.; Matos, Ignacio; Bennouna, Jaafar; Kim, Dong-Wan; Xu, Lei; Krishnan, Suba; Norwood, Kevin; Ott, Patrick A. Journal of Thoracic Oncology, Vol.15 No.4, pp.618-627	DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI
2016-06	Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial Muro, Kei; Chung, Hyun Cheol; Shankaran, Veena; Geva, Ravit; Catenacci, Daniel; Gupta, Shilpa; Eder, Joseph Paul; Golan, Talia; Le, Dung T.; Burtness, Barbara; McRee, Autumn J.; Lin, Chia-Chi; Pathiraja, Kumudu; Lunceford, Jared; Emancipator, Kenneth; Juco, Jonathan; Koshiji, Minori; Bang, Yung-Jue The Lancet Oncology, Vol.17 No.6, pp.717-726	DOI
2018-03	Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 Tahara, Makoto; Muro, Kei; Hasegawa, Yasuhisa; Chung, Hyun Cheol; Lin, Chia-Chi; Keam, Bhumsuk; Takahashi, Kenichi; Cheng, Jonathan D.; Bang, Yung-Jue Cancer Science, Vol.109 No.3, pp.771-776	DOI
2017-12	Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study Ott, Patrick A.; Elez, Elena; Hiret, Sandrine; Kim, Dong-Wan; Morosky, Anne; Saraf, Sanatan; Piperdi, Bilal; Mehnert, Janice M. Journal of Clinical Oncology, Vol.35 No.34, pp.3823-3829	DOI
2020-05	Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study Schmid, P.; Salgado, R.; Park, Y. H.; Munoz-Couselo, E.; Kim, S. B.; Sohn, J.; Im, S. -A.; Foukakis, T.; Kuemmel, S.; Dent, R.; Yin, L.; Wang, A.; Tryfonidis, K.; Karantza, V.; Cortes, J.; Loi, S. Annals of Oncology, Vol.31 No.5, pp.569-581	DOI
2023-11	Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter Jama Network Open, Vol.6 No.11, p. e2342107	DOI
2022-07	Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer Cortes, Javier; Rugo, Hope S.; Cescon, David W.; Im, Seock-Ah; Yusof, Mastura M.; Gallardo, Carlos; Lipatov, Oleg; Barrios, Carlos H.; Perez-Garcia, Jose; Iwata, Hiroji; Masuda, Norikazu; Otero, Marco Torregroza; Gokmen, Erhan; Loi, Sherene; Guo, Zifang; Zhou, Xuan; Karantza, Vassiliki; Pan, Wilbur; Schmid, Peter New England Journal of Medicine, Vol.387 No.3, pp.217-226	DOI
2020-12	Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial Cortes, Javier; Cescon, David W.; Rugo, Hope S.; Nowecki, Zbigniew; Im, Seock-Ah; Yusof, Mastura Md; Gallardo, Carlos; Lipatov, Oleg; Barrios, Carlos H.; Holgado, Esther; Iwata, Hiroji; Masuda, Norikazu; Torregroza Otero, Marco; Gokmen, Erhan; Loi, Sherene; Guo, Zifang; Zhao, Jing; Aktan, Gursel; Karantza, Vassiliki; Schmid, Peter The Lancet, Vol.396 No.10265, pp.1817-1828	DOI
2016-04	Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial Herbst, Roy S.; Baas, Paul; Kim, Dong-Wan; Felip, Enriqueta; Perez-Gracia, Jose L.; Han, Ji-Youn; Molina, Julian; Kim, Joo-Hang; Arvis, Catherine Dubos; Ahn, Myung-Ju; Majem, Margarita; Fidler, Mary J.; de Castro, Gilberto, Jr.; Garrido, Marcelo; Lubiniecki, Gregory M.; Shentu, Yue; Im, Ellie; Dolled-Filhart, Marisa; Garon, Edward B. The Lancet, Vol.387 No.10027, pp.1540-1550	DOI
2021-04	Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial Winer, Eric P.; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Munoz-Couselo, Eva; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Zhou, Xuan; Karantza, Vassiliki; Mejia, Jaime; Cortes, Javier The Lancet Oncology, Vol.22 No.4, pp.499-511	DOI
2022-01	Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial Fuchs, Charles S.; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Van Cutsem, Eric; Elme, Anneli; Thuss-Patience, Peter; Chau, Ian; Ohtsu, Atsushi; Bhagia, Pooja; Wang, Anran; Shih, Chie-Schin; Shitara, Kohei Gastric Cancer, Vol.25 No.1, pp.197-206	DOI
2018-07	Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): A randomised, open-label, controlled, phase 3 trial Shitara, Kohei; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Goekkurt, Eray; Mansoor, Wasat; McDermott, Raymond S.; Shacham-Shmueli, Einat; Chen, Xinqun; Mayo, Carlos; Kang, S. Peter; Ohtsu, Atsushi; Fuchs, Charles S. The Lancet, Vol.392 No.10142, pp.123-133	DOI
2008-07	Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study Kim, Yeul Hong; Chung, Hyun Cheol; Kang, Won Ki; Park, Sook Ryun; Kim, Chul Soo; Kim, Tae-Yue; Shin, Sang Won; Park, Byung-Joo; Cha, Soo Jin; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.62 No.2, pp.263-270	DOI
2019-07	Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer Choi, Mihong; Keam, Bhumsuk; Ock, Chan-Young; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Clinical Lung Cancer, Vol.20 No.4, pp.E442-E451	DOI
2024-01	Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial Lee, Dae-Won; Jung, Kyung Hae; Lee, Kyung-Hun; Park, Yeon Hee; Lee, Keun Seok; Sohn, Joohyuk; Ahn, Hee Kyung; Jeong, Jae Ho; Koh, Su-Jin; Kim, Jee Hyun; Kim, Han Jo; Lee, Kyoung Eun; Kim, Hee-Jun; Yang, Yae-Won; Park, Kyong Hwa; Lee, Jieun; Won, Hye Sung; Kim, Tae-Yong; Im, Seock-Ah European Journal of Cancer, Vol.197, p. 113456	DOI
2015-10	Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations Park, Sehhoon; Keam, Bhumsuk; Kim, Se Hyun; Kim, Ki Hwan; Kim, Yu Jung; Kim, Jin-Soo; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Cancer Research and Treatment, Vol.47 No.4, pp.630-637	view file DOI
2023-03	Penetrative and Sustained Drug Delivery Using Injectable Hydrogel Nanocomposites for Postsurgical Brain Tumor Treatment Kang, Taegyu; Cha, Gi Doo; Park, Ok Kyu; Cho, Hye Rim; Kim, Minjeong; Lee, Jongha; Kim, Dokyoon; Lee, Bowon; Chu, Jinyoung; Koo, Sagang; Hyeon, Taeghwan; Kim, Dae-Hyeong; Choi, Seung Hong ACS Nano, Vol.17 No.6, pp.5435-5447	DOI
2010-11	Penicillamine-induced Elastosis Perforans Serpiginosa and Cutis Laxa in a Patient with Wilson's Disease Na, Se Young; Choi, Mira; Kim, Min Ji; Lee, Jong Hee; Cho, Soyun Annals of Dermatology, Vol.22 No.4, pp.468-471	DOI
2010-11	Penicillamine-induced elastosis perforans serpiginosa and cutis laxa in a patient with Wilson's disease Na, Se Young; Choi, Mira; Kim, Min Ji; Lee, Jong Hee; Cho, Soyun Annals of Dermatology, Vol.22 No.4, pp. 468-471	view file DOI

1 545 546 547 548 549 550 551 994